Jin Kyun Park Selected Research

Jin Kyun Park Research Topics

Disease

26	Rheumatoid Arthritis 07/2023 - 12/2011
7	Human Influenza (Influenza) 02/2024 - 09/2017
6	Ankylosing Spondylitis 03/2024 - 09/2014
6	Inflammation (Inflammations) 10/2020 - 08/2013
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2024 - 12/2016
5	Arthritis (Polyarthritis) 01/2021 - 04/2016
4	Gout 10/2021 - 05/2014
4	Osteoarthritis 10/2021 - 08/2016
3	Infections 11/2023 - 09/2014
3	Vasculitis (Vasculitides) 03/2019 - 06/2010
3	Tuberculosis (Tuberculoses) 02/2016 - 08/2013
2	Fever (Fevers) 05/2024 - 12/2017
2	Herpes Zoster 05/2024 - 06/2020
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 04/2024 - 01/2022
2	COVID-19 11/2023 - 01/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 07/2023 - 01/2023
2	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021 - 01/2016
2	Hypertension (High Blood Pressure) 01/2021 - 01/2020
2	Dermatomyositis (Dermatopolymyositis) 03/2019 - 01/2016
2	Systemic Scleroderma (Systemic Sclerosis) 07/2016 - 01/2016
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 08/2013 - 06/2010
1	Fatigue 05/2024
1	Injection Site Reaction 05/2024
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024
1	Axial Spondyloarthritis 03/2024
1	Back Pain (Backache) 03/2024
1	Diabetes Mellitus 03/2024
1	Communicable Diseases (Infectious Diseases) 02/2024
1	Rheumatic Diseases (Rheumatism) 02/2024
1	Contracture 07/2023
1	Sepsis (Septicemia) 04/2023
1	Glaucoma 01/2023
1	Uveitis 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Cataract (Cataracts) 01/2023
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2022
1	Hypersensitivity (Allergy) 03/2021
1	Anaphylaxis (Anaphylactic Shock) 03/2021
1	Pneumonia (Pneumonitis) 10/2020
1	Whooping Cough (Pertussis) 06/2020
1	Hepatitis B 06/2020
1	Hepatitis A (Hepatitis, Infectious) 06/2020
1	Tetanus 06/2020
1	Measles 06/2020
1	Diphtheria 06/2020
1	Mumps 06/2020

Drug/Important Bio-Agent (IBA)

8	C-Reactive ProteinIBA 03/2024 - 03/2012
8	Methotrexate (Mexate)FDA LinkGeneric 07/2023 - 09/2017
5	VaccinesIBA 05/2024 - 06/2020
4	CytokinesIBA 01/2022 - 01/2015
3	GlucocorticoidsIBA 04/2024 - 04/2023
3	AntigensIBA 03/2024 - 01/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2023 - 06/2015
3	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2015
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 01/2017
3	Histone Deacetylase 6IBA 01/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2016
3	Uric Acid (Urate)IBA 06/2019 - 05/2014
3	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 09/2014
3	Interleukin-17 (Interleukin 17)IBA 01/2017 - 10/2014
3	Proteins (Proteins, Gene)FDA Link 11/2015 - 07/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 01/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 04/2023 - 11/2018
2	Pyruvate KinaseIBA 02/2023 - 01/2022
2	AutoantibodiesIBA 01/2023 - 01/2023
2	AntibodiesIBA 01/2023 - 11/2017
2	InterleukinsIBA 01/2022 - 10/2018
2	Therapeutic UsesIBA 03/2021 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2016
2	Carbon MonoxideIBA 03/2019 - 10/2015
2	LipidsIBA 10/2018 - 01/2016
2	Lipoproteins (Lipoprotein)IBA 12/2016 - 01/2016
2	Peptides (Polypeptides)IBA 07/2016 - 02/2016
2	Cathepsin KIBA 02/2016 - 08/2013
1	Subunit VaccinesIBA 05/2024
1	ruxolitinibIBA 04/2024
1	Messenger RNA (mRNA)IBA 02/2024
1	mRNA VaccinesIBA 02/2024
1	Influenza Vaccines (Influenza Vaccine)FDA Link 07/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	ZincIBA 11/2022
1	Aromatase InhibitorsIBA 10/2022
1	Analgesics (Analgesic Drugs)IBA 10/2022
1	Infliximab (Remicade)FDA Link 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	tofacitinibIBA 12/2021
1	Janus Kinase InhibitorsIBA 12/2021
1	RANK LigandIBA 10/2021
1	Macrophage Colony-Stimulating FactorIBA 10/2021
1	COVID-19 VaccinesIBA 03/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	CKD-506IBA 01/2020
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2020

Therapy/Procedure

3	Therapeutics 01/2017 - 09/2014
2	Drug Tapering 03/2024 - 01/2016
1	Intramuscular Injections 05/2024